Sutro Biopharma (STRO) Research & Development (2017 - 2025)
Historic Research & Development for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to $39.9 million.
- Sutro Biopharma's Research & Development fell 3583.27% to $39.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $200.8 million, marking a year-over-year decrease of 1446.47%. This contributed to the annual value of $252.0 million for FY2024, which is 3969.41% up from last year.
- Sutro Biopharma's Research & Development amounted to $39.9 million in Q3 2025, which was down 3583.27% from $38.3 million recorded in Q2 2025.
- In the past 5 years, Sutro Biopharma's Research & Development ranged from a high of $71.0 million in Q4 2024 and a low of $22.6 million during Q1 2021
- Moreover, its 5-year median value for Research & Development was $39.9 million (2025), whereas its average is $42.3 million.
- As far as peak fluctuations go, Sutro Biopharma's Research & Development soared by 4911.52% in 2024, and later tumbled by 3820.54% in 2025.
- Quarter analysis of 5 years shows Sutro Biopharma's Research & Development stood at $29.9 million in 2021, then surged by 44.13% to $43.1 million in 2022, then rose by 24.64% to $53.8 million in 2023, then soared by 32.12% to $71.0 million in 2024, then tumbled by 43.9% to $39.9 million in 2025.
- Its Research & Development stands at $39.9 million for Q3 2025, versus $38.3 million for Q2 2025 and $51.6 million for Q1 2025.